Thymalin

Thymalin is a standardized polypeptide complex extracted from calf thymus gland, developed in Russia as an immunomodulatory agent. Unlike single-peptide thymic hormones such as thymosin alpha-1, thymalin represents a mixture of bioactive peptides that collectively reproduce the thymus gland's immune-regulatory functions.

The thymus gland plays an essential role in T-cell development and immune system education, but undergoes progressive involution with age, contributing to immunosenescence. Thymalin supplementation aims to provide exogenous thymic factors that compensate for this age-related decline, potentially restoring more youthful immune function.

Clinical research in Russia has investigated thymalin for a range of conditions including chronic infections, cancer immunotherapy support, autoimmune diseases, and general immune enhancement in elderly populations. Studies suggest improvements in T-cell counts, T-cell subpopulation ratios, and functional immune parameters following treatment.

Longevity research has shown particular interest in thymalin as part of peptide bioregulator protocols. Studies by Khavinson and colleagues demonstrated that thymalin administration to elderly subjects improved immune function markers and, in some reports, was associated with reduced mortality over extended follow-up periods. These findings position thymalin as a candidate for anti-aging immune support strategies.